Hydroxyzine vs Buspirone
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Hydroxyzine and buspirone are both non-benzodiazepine medications used to treat anxiety, but they work through entirely different pharmacological mechanisms and are suited to different clinical scenarios [1][2].
Hydroxyzine is a first-generation antihistamine with anxiolytic, sedative, and antiemetic properties [1]. It works primarily by blocking histamine H1 receptors in the central nervous system. Available as hydroxyzine hydrochloride (Atarax) and hydroxyzine pamoate (Vistaril), it is FDA-approved for anxiety, pruritus (itching), and as a preoperative sedative [1]. Its onset of action is rapid (15-30 minutes), making it useful for acute anxiety episodes.
Buspirone (brand name BuSpar) is a serotonin 5-HT1A partial agonist that represents a completely different approach to anxiety treatment [2]. Unlike hydroxyzine, buspirone has no sedative, muscle relaxant, or anticonvulsant properties. It is FDA-approved specifically for generalized anxiety disorder (GAD) [2]. Its therapeutic effects develop gradually over 2-4 weeks of consistent use, similar to antidepressants.
Hydroxyzine vs Buspirone: Side-by-side comparison
| Category | Hydroxyzine | Buspirone |
|---|---|---|
| Drug Class | First-generation antihistamine | Azapirone (5-HT1A partial agonist) |
| Brand Names | Atarax, Vistaril | BuSpar |
| FDA-Approved Uses | Anxiety, pruritus, preoperative sedation | Generalized anxiety disorder (GAD) |
| Typical Dosage | 25-100 mg up to 4 times daily | 15-60 mg/day in 2-3 divided doses |
| Onset of Action | 15-30 minutes | 2-4 weeks (full effect) |
| Common Side Effects | Drowsiness, dry mouth, dizziness | Dizziness, nausea, headache |
| Sedation | Significant | Minimal to none |
| Abuse Potential | Very low | None |
| Physical Dependence | No | No |
| Half-Life | ~20 hours | 2-3 hours |
| Generic Cost (30-day) | $4-$12 | $4-$15 |
Efficacy: How well does each drug work?
Hydroxyzine and buspirone target anxiety through fundamentally different timelines and mechanisms [1][2].
Hydroxyzine provides rapid anxiolytic effects within 15-30 minutes of oral administration, with peak effects at 1-2 hours and a duration of 4-6 hours [1]. Clinical trials have demonstrated its superiority over placebo for acute anxiety symptoms [3]. However, tolerance to its anxiolytic effects can develop with regular use, and it is not well-suited for long-term daily management of GAD.
Buspirone requires 2-4 weeks of consistent twice-daily dosing before therapeutic effects emerge [2]. In clinical trials for GAD, buspirone 15-60 mg/day demonstrated significant improvement in Hamilton Anxiety Rating Scale scores compared to placebo [4]. Meta-analyses have found buspirone comparable to benzodiazepines for GAD when given adequate time to work, with no abuse potential or physical dependence [4].
In clinical practice, the two medications are sometimes used together — buspirone for ongoing GAD management and hydroxyzine for breakthrough acute anxiety episodes [3][4].
Side effects comparison
Hydroxyzine's most common side effects are driven by its antihistamine activity: drowsiness and sedation (the most prominent effect), dry mouth, dizziness, headache, and blurred vision [1]. It can prolong the QT interval, increasing the risk of cardiac arrhythmias [1]. It should be used cautiously in patients with cardiac disease or those taking other QT-prolonging medications.
Buspirone's most common side effects include dizziness (12%), nausea (8%), headache (6%), nervousness (5%), and lightheadedness (3%) [2]. Notably, buspirone does not cause sedation, cognitive impairment, or psychomotor slowing. It does not cause physical dependence, has no withdrawal syndrome, and has essentially no abuse potential [2][4].
Buspirone has a wide therapeutic index and is rarely fatal in overdose, unlike hydroxyzine, which can cause serious toxicity (seizures, cardiac arrhythmias) in large overdoses [1][2].
Cost comparison
Both hydroxyzine and buspirone are available as inexpensive generics [5].
Generic hydroxyzine (10-50 mg) typically costs $4-$12 for a 30-day supply. Generic buspirone (5-30 mg tablets) costs $4-$15 for a 30-day supply. Both are widely available at $4 generic programs at major pharmacies. Insurance coverage is standard for both.
Convenience and dosing
Hydroxyzine is taken on an as-needed basis or up to 3-4 times daily, with dosing flexibility that allows patients to use it only when anxiety is acute [1].
Buspirone must be taken consistently 2-3 times daily to maintain therapeutic blood levels [2]. Missing doses can reduce its effectiveness. Both medications are available only as oral formulations.
Which is right for you?
Hydroxyzine may be preferred for acute anxiety episodes, preoperative anxiety, anxiety with insomnia, or as a bridge while waiting for other medications to take effect [1][3]. Its rapid onset provides immediate relief.
Buspirone is preferred for long-term management of GAD, when sedation must be avoided, when abuse potential is a concern (e.g., patients with substance use history), or as an augmentation strategy for partial SSRI response [2][4].
This information is for educational purposes only and does not constitute medical advice. Consult your healthcare provider to determine which anxiety treatment is appropriate for your situation.
Frequently asked questions
References
- [Regulatory] Vistaril (hydroxyzine pamoate) prescribing information. Pfizer. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/011459s033lbl.pdf Accessed 2026-02-28.
- [Regulatory] BuSpar (buspirone HCl) prescribing information. Bristol-Myers Squibb. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/018731s032lbl.pdf Accessed 2026-02-28.
- [Regulatory] Guaiana G, et al. Hydroxyzine for generalised anxiety disorder. Cochrane Database Syst Rev. 2010. https://doi.org/10.1002/14651858.CD006927.pub2 Accessed 2026-02-28.
- [Regulatory] Chessick CA, et al. Azapirones for generalized anxiety disorder. Cochrane Database Syst Rev. 2006. https://doi.org/10.1097/JCP.0b013e3181ca4b14 Accessed 2026-02-28.
- [Observational] GoodRx. Current pricing for generic hydroxyzine and buspirone. https://www.goodrx.com/ Accessed 2026-02-28.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: